The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2015

Filed:

Jun. 20, 2008
Applicants:

Andreas Lutz, Seefeld, DE;

Harald Eizenhofer, Seefeld, DE;

Andreas Michael Zeiher, Frankfurt, DE;

Stefanie Dimmeler, Frankfurt, DE;

Christopher Heeschen, Munich, DE;

Alexandra Aicher, Frankfurt, DE;

Inventors:

Andreas Lutz, Seefeld, DE;

Harald Eizenhofer, Seefeld, DE;

Andreas Michael Zeiher, Frankfurt, DE;

Stefanie Dimmeler, Frankfurt, DE;

Christopher Heeschen, Munich, DE;

Alexandra Aicher, Frankfurt, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61H 23/00 (2006.01); A61B 17/22 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 35/44 (2015.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61H 23/008 (2013.01); A61B 17/22004 (2013.01); A61B 2017/00247 (2013.01); A61B 2018/00392 (2013.01); A61K 38/1866 (2013.01); A61K 38/195 (2013.01); A61K 35/44 (2013.01);
Abstract

Improving cell therapy and tissue regeneration in a patient suffering from a cardiovascular or a neurological disease by treating a tissue of the patient with shock waves and/or applying to the patient a therapeutically effective amount of stem cells and/or progenitor cells. Such treatment increases expression of chemoattractants, pro-angiogenic factors, and pro-survival factors. The chemoattractants can be, for example, vascular endothelial growth factor (VEGF) or stromal cell derived factor 1 (SDF-1). For example, the treated tissue can be located in the patient's heart or in a skeletal muscle of the patient, and the shock waves can be extracorporeal shock waves (ESW) or intracorporeal shock waves. The cardiovascular disease can have an ischemic or non-ischemic etiology. For example, the cardiovascular disease can be a myocardial infarction, ischemic cardiomyopathy, or a dilatative cardiomyopathy. For example, the neurological disease can be a peripheral neuropathy or neuropathic pain.


Find Patent Forward Citations

Loading…